X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Asia

The 9th Asian & Oceanic epilepsy Congress

Yuvraj_pawp by Yuvraj_pawp
5th October 2015
in Asia, News

The 9th Asian & Oceanic epilepsy Congress was recently concluded in Manilla, Phillipines. In this conference UCB had brought together 4 key experts from various parts of the world to deliberate on a symposium titled

The symposium learning objectives were

1)Make an optimal use of current practices to diagnose epilepsy
2) Provide insight on how to manage patients with uncontrolled epilepsy and expose related challenges
3) Optimize care of patients through improved understanding of the available treatment options. The session was started by a deliberation presented by Dr Byung In Lee, MD.

Dr Byung Lee is the current chair of Commission of Asian Oceanian Affairs in ILAE and president of Korean Neurocritical Society. His session was centered on “Diagnosing epilepsy – what are the key ingredients?” This session really challenged the way epilepsy is diagnosed and also brought out the shortcomings of the older diagnostic techniques and also rpesented the newer diagnostic process.

This was followed by Prof Ernest Somerville, MD. His topic covered “Challenges in the treatment of uncontrolled epilepsy”.Ernest Somerville is Director of the Comprehensive Epilepsy Service of the Prince of Wales Hospital in Sydney and Associate Professor at the University of New South Wales.

Dr Patrick Kwans then presented his views on “First becoming last. Selecting an optimal therapeutic choice”. Professor Patrick Kwan is Chair of Neurology at the University of Melbourne, Royal Melbourne Hospital, Australia, and Associate Consultant at the Prince of Wales Hospital, Hong Kong. He is currently President of the Hong Kong Epilepsy Society, treasurer of the ILAE Commission on Therapeutic Strategies, and chair of the CAOA Research Task Force, and was chair of the task force for the definition of drug-resistant epilepsy

Finally Dr Salim Benbadis presentation on “ A critical comparative review of AEDs.” Dr. Benbadis is currently Professor of Neurology in the departments of Neurology and Neurosurgery at the University of South Florida. He is Director of the University of South Florida /Tampa General Hospital Comprehensive Epilepsy Program. The sessions brought in great insight into diagnosis, management of Epilepsy and on parameters of how to choose the right AED. This session was attended by more than 800 neurologists. UCB has the rights to this entire presentation and is proud to announce that this entire session will be available on the UCB website for the next 15 days for viewing. If your department would like to view the entire session, UCB would be very happy to organise a viewing session for your entire department. Alternately if you wish to view it then you need to visit the UCB website to see this session. The session lasts for 1 hours and 30 mins and is most informative and challenges many widely held beliefs and proposed newer methods for diagnosis and management of epilepsy.

Tags: Middle East & South Asia
Previous Post

Study Links Early Infections to Celiac Risk

Next Post

Roche receives FDA CLIA waiver for flu A/B test for use on its cobas Liat PCR System

Related Posts

SCHOTT Pharma Invests
News

SCHOTT Pharma Invests EUR 100 Million in RTU Cartridges

9th June 2025
Stringent Policy around COVID Vaccines Laid by FDA
FDA Approvals

Stringent Policy around COVID Vaccines Laid by FDA

29th May 2025
Pharmaceutical-Chemicals Market Booms with Rising API Demand
Asia

Pharmaceutical Chemicals Market Booms with Rising API Demand

28th May 2025
Drugmakers Asked to Strictly Follow the US Pricing Reforms
Manufacturing

Drugmakers Asked to Strictly Follow the US Pricing Reforms

28th May 2025
Getty images
Articles

Recombinant DNA Technology Market: A Growth Revolution

19th April 2025
Development Market Growth
Articles

Asia-Pacific Biologics Contract Development Market Growth

19th April 2025
Next Post

Roche receives FDA CLIA waiver for flu A/B test for use on its cobas Liat PCR System

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In